Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas
Status:
Active, not recruiting
Trial end date:
2022-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an extended maintenance therapy with Rituximab
in follicular and a maintenance therapy in other indolent and mantle cell lymphomas has
advantages compared to a shorter or no maintenance therapy.